+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hepatitis B & C Detection Kits Market - Global Forecast 2026-2032- Product Image
Hepatitis B & C Detection Kits Market - Global Forecast 2026-2032- Product Image
Sale

Hepatitis B & C Detection Kits Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144967
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hepatitis B & C Detection Kits Market is projected to reach USD 5.82 Billion in 2026. It is expected to continue growing at a CAGR of 10.91%, reaching USD 10.78 Billion by 2032.

Hepatitis B and C Detection Kits: Executive Summary

Hepatitis B virus (HBV) and hepatitis C virus (HCV) detection kits support screening, diagnosis, treatment decisions, and public-health surveillance. The market is shaped by the different clinical pathways of the two infections: HBV commonly requires serological assessment and, when indicated, nucleic-acid testing, while HCV diagnosis generally begins with antibody testing followed by confirmatory RNA testing. Global demand is closely linked to elimination programs, blood-safety requirements, antenatal screening, harm-reduction services, and access to decentralized testing.

Screening Pathways and Decentralized Testing Are Reshaping the Landscape

The sector is shifting from facility-centered testing toward integrated pathways that connect community screening, confirmatory diagnostics, linkage to care, and treatment monitoring. Rapid diagnostic tests can improve access where laboratory infrastructure is limited, while laboratory-based immunoassays and molecular methods remain important for confirmation and clinical management. Regulatory scrutiny increasingly emphasizes analytical sensitivity, specimen quality, usability, quality controls, and evidence that testing strategies reach underserved populations without weakening diagnostic accuracy.

Artificial Intelligence Strengthens Workflow, Interpretation, and Surveillance

Artificial intelligence is contributing to the surrounding diagnostic workflow rather than replacing validated assay chemistry. Potential applications include instrument flagging, image and signal interpretation, quality-control review, demand planning, laboratory workflow optimization, and identification of patients who may benefit from follow-up testing. Effective deployment depends on representative validation data, transparent performance monitoring, cybersecurity, interoperability, and human oversight. AI can improve operational consistency, but it cannot compensate for inadequate specimens, weak confirmatory pathways, or poor linkage to care.

Regional Insights: Uneven Access Determines Testing Priorities

North America emphasizes laboratory quality, screening of at-risk populations, blood safety, and integration with primary care and public-health systems. Europe combines established laboratory networks with elimination-oriented testing, migration-sensitive screening, and stronger cross-border standards. Asia-Pacific contains substantial unmet diagnostic need alongside advanced national programs, making decentralized and scalable testing particularly relevant. Latin America is prioritizing earlier diagnosis, expanded screening, and improved access beyond major urban centers. The Middle East is balancing specialized laboratory capacity with migrant, antenatal, and blood-safety screening needs. Africa faces high HBV and HCV burdens in many settings and places particular value on affordable, robust, near-patient testing linked to treatment and prevention services.

Group Insights: Regional Alliances Can Accelerate Standards and Access

ASEAN countries can benefit from interoperable procurement, shared evaluation practices, and cross-border approaches to migrant and mobile populations. BRICS members represent diverse health-system conditions, creating opportunities for locally appropriate manufacturing, laboratory strengthening, and coordinated public-health learning while retaining national regulatory control. The European Union benefits from common technical standards and coordinated elimination initiatives, although implementation differs among member states. G7 systems tend to emphasize advanced laboratory quality, surveillance, and innovation alongside equity obligations. GCC countries are positioned to expand coordinated screening through centralized health systems, occupational programs, and migrant-health services. NATO members can apply resilient procurement, supply continuity, and laboratory preparedness principles to infectious-disease diagnostics.

Country Insights: National Priorities Shape Adoption and Use

Australia combines strong laboratory governance with targeted screening and culturally responsive services for remote and Indigenous communities. Brazil’s priorities include decentralizing diagnosis and connecting testing with public-health treatment networks. Canada emphasizes equitable access across provinces, territories, and remote communities. China is strengthening screening, laboratory capacity, and public-health surveillance across a large and diverse system. France, Germany, Italy, Spain, and the United Kingdom focus on case finding, high-quality confirmation, and linkage to specialist or primary care, with distinct national reimbursement and screening arrangements. India is prioritizing scale, affordability, and access across varied health facilities. Japan and South Korea maintain sophisticated laboratory infrastructure while addressing aging populations and targeted-risk screening. Mexico is expanding access beyond major urban centers and strengthening referral pathways. Russia’s needs include geographically distributed testing, laboratory quality, and continuity of care. The United States combines broad laboratory capacity with efforts to improve screening, confirmatory testing, and access among underserved groups.

Industry Priorities: Build Reliable, Connected, and Equitable Testing Pathways

Leaders should design portfolios around complete diagnostic algorithms rather than isolated products, clearly separating screening from confirmation and treatment-monitoring use cases. They should validate performance across relevant specimen types and populations, invest in quality controls and external assessment, and support connectivity with laboratory and public-health information systems. Commercial and implementation strategies should account for procurement rules, reimbursement, decentralized settings, training, waste management, and continuity of supply. Partnerships with health authorities and care providers can improve linkage to treatment, while transparent evidence on usability, accuracy, and real-world performance can strengthen adoption without overstating clinical claims.

Research Methodology: Evidence-Based Assessment of Diagnostic Market Dynamics

This executive summary uses a structured review of established public-health guidance, regulatory principles, diagnostic pathway requirements, laboratory practice, and regional health-system characteristics. The assessment distinguishes HBV and HCV testing roles, including screening, confirmation, and monitoring, and considers how infrastructure, epidemiology, policy, procurement, and access influence adoption. Regional, group, and country observations are synthesized from documented health-system patterns and implementation priorities. Claims are limited to qualitative, data-backed insights; no market estimates, market shares, forecasts, or company-specific assessments are included.

Conclusion: Diagnostic Access Must Connect Accuracy With Care

The hepatitis B and C detection-kit landscape is being shaped by elimination objectives, decentralized care, laboratory quality, and the need to connect positive results with treatment and prevention. Regional and national conditions require differentiated implementation, while group-level cooperation can support standards, supply resilience, and shared learning. Artificial intelligence may improve workflows and surveillance when governed responsibly, but reliable assays, appropriate confirmatory testing, trained personnel, and effective referral systems remain foundational. Industry leaders that combine technical performance with equitable deployment are best positioned to support meaningful public-health outcomes.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Hepatitis B & C Detection Kits Market, by Product
7.1. Introduction
7.2. Instruments
7.3. Kits
7.4. Reagents
8. Hepatitis B & C Detection Kits Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.2.1. CLIA
8.2.2. ELISA
8.2.3. FLIA
8.3. Molecular
8.3.1. NASBA
8.3.2. Real Time PCR
8.3.3. TMA
8.4. Rapid Diagnostic
8.4.1. Cassette Test
8.4.2. Lateral Flow Assay
9. Hepatitis B & C Detection Kits Market, by Sample Type
9.1. Introduction
9.2. Plasma
9.3. Serum
9.4. Whole Blood
10. Hepatitis B & C Detection Kits Market, by Application
10.1. Introduction
10.2. Diagnosis
10.3. Monitoring
10.4. Screening
11. Hepatitis B & C Detection Kits Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Labs
11.4. Hospitals
11.5. Research Institutes
12. Hepatitis B & C Detection Kits Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Hepatitis B & C Detection Kits Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Hepatitis B & C Detection Kits Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Abcam plc
16.3. Artron Laboratories Inc.
16.4. Becton, Dickinson and Company
16.5. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
16.6. BioMérieux SA
16.7. Bio-Rad Laboratories, Inc.
16.8. Creative Diagnostics
16.9. Danaher Corporation
16.10. DiaSorin S.p.A.
16.11. Fujirebio Holdings, Inc.
16.12. Genrui Biotech Inc.
16.13. Hologic, Inc.
16.14. Immuno Diagnostics (Pvt) Ltd.
16.15. Immunostics, Inc.
16.16. Ortho Clinical Diagnostics, Inc.
16.17. QuidelOrtho Corporation
16.18. Roche Diagnostics International AG
16.19. SD Biosensor, Inc.
16.20. Sekisui Diagnostics LLC
16.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.22. Siemens Healthineers AG
16.23. Snibe Co., Ltd.
16.24. Teco Diagnostics
16.25. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Hepatitis B & C Detection Kits Market, Years Considered for the Study
FIGURE 2. Global Hepatitis B & C Detection Kits Market, Research Design
FIGURE 3. Global Hepatitis B & C Detection Kits Market, Research Framework
FIGURE 4. Global Hepatitis B & C Detection Kits Market, Data Triangulation
FIGURE 5. Global Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Hepatitis B & C Detection Kits Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Hepatitis B & C Detection Kits Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Hepatitis B & C Detection Kits Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Hepatitis B & C Detection Kits Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Hepatitis B & C Detection Kits Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Hepatitis B & C Detection Kits Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Hepatitis B & C Detection Kits Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Hepatitis B & C Detection Kits Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Hepatitis B & C Detection Kits Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Hepatitis B & C Detection Kits Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Hepatitis B & C Detection Kits Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Hepatitis B & C Detection Kits Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Hepatitis B & C Detection Kits Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Hepatitis B & C Detection Kits Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Hepatitis B & C Detection Kits Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Hepatitis B & C Detection Kits Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Hepatitis B & C Detection Kits Market Segmentation & Coverage
TABLE 2. Global Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 3. Global Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 14. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global CLIA Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global CLIA Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global CLIA Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global FLIA Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global FLIA Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global FLIA Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Molecular Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Molecular Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Molecular Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global NASBA Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global NASBA Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global NASBA Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global TMA Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global TMA Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global TMA Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Rapid Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Rapid Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Rapid Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Cassette Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Cassette Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Cassette Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 48. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Global Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Diagnostic Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Diagnostic Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Diagnostic Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. North America Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. North America Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 92. North America Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 93. North America Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 94. North America Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 95. North America Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 96. North America Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 97. North America Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Latin America Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Latin America Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 101. Latin America Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Latin America Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 103. Latin America Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 104. Latin America Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 105. Latin America Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 106. Latin America Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Latin America Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Europe Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Europe Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 110. Europe Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. Europe Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 112. Europe Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 113. Europe Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 114. Europe Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 115. Europe Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. Europe Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Middle East Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Middle East Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 119. Middle East Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 120. Middle East Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 121. Middle East Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 122. Middle East Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 123. Middle East Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 124. Middle East Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Middle East Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Africa Hepatitis B & C Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Africa Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. Africa Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. Africa Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 130. Africa Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 131. Africa Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 132. Africa Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 133. Africa Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Africa Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Global Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. ASEAN Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 138. ASEAN Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. ASEAN Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 140. ASEAN Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 141. ASEAN Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 142. ASEAN Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 143. ASEAN Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. ASEAN Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. GCC Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. GCC Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 147. GCC Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. GCC Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 149. GCC Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 150. GCC Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 151. GCC Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. GCC Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. GCC Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. European Union Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. European Union Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 156. European Union Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. European Union Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 158. European Union Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 159. European Union Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 160. European Union Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 161. European Union Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. European Union Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. BRICS Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. BRICS Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 165. BRICS Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. BRICS Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 167. BRICS Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 168. BRICS Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 169. BRICS Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. BRICS Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. BRICS Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. G7 Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. G7 Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 174. G7 Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. G7 Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 176. G7 Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 177. G7 Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 178. G7 Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 179. G7 Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. G7 Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. NATO Hepatitis B & C Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. NATO Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 183. NATO Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. NATO Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 185. NATO Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 186. NATO Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 187. NATO Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 188. NATO Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. NATO Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Global Hepatitis B & C Detection Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. United States Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 192. United States Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 193. United States Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. United States Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 195. United States Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 196. United States Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 197. United States Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 198. United States Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. United States Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Canada Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 201. Canada Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 202. Canada Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Canada Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 204. Canada Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 205. Canada Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 206. Canada Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 207. Canada Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Canada Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Mexico Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 210. Mexico Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 211. Mexico Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 212. Mexico Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 213. Mexico Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 214. Mexico Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 215. Mexico Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. Mexico Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Mexico Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Brazil Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 219. Brazil Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 220. Brazil Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. Brazil Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 222. Brazil Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 223. Brazil Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 224. Brazil Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 225. Brazil Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Brazil Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. United Kingdom Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 228. United Kingdom Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 229. United Kingdom Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. United Kingdom Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 231. United Kingdom Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 232. United Kingdom Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 233. United Kingdom Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 234. United Kingdom Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. United Kingdom Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Germany Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 237. Germany Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 238. Germany Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 239. Germany Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 240. Germany Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 241. Germany Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 242. Germany Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 243. Germany Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Germany Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. France Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 246. France Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 247. France Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. France Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 249. France Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 250. France Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 251. France Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 252. France Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. France Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Russia Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 255. Russia Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 256. Russia Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. Russia Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 258. Russia Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 259. Russia Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 260. Russia Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 261. Russia Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Russia Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Italy Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 264. Italy Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 265. Italy Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Italy Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 267. Italy Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 268. Italy Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 269. Italy Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 270. Italy Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Italy Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Spain Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 273. Spain Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 274. Spain Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 275. Spain Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 276. Spain Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 277. Spain Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 278. Spain Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 279. Spain Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Spain Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. China Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 282. China Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 283. China Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 284. China Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 285. China Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 286. China Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 287. China Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 288. China Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. China Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. India Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 291. India Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 292. India Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. India Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 294. India Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 295. India Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 296. India Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 297. India Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. India Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Japan Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 300. Japan Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 301. Japan Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 302. Japan Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 303. Japan Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 304. Japan Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 305. Japan Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 306. Japan Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Japan Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Australia Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 309. Australia Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 310. Australia Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 311. Australia Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 312. Australia Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 313. Australia Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 314. Australia Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 315. Australia Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. Australia Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. South Korea Hepatitis B & C Detection Kits Market Size, 2017-2032 (USD Million)
TABLE 318. South Korea Hepatitis B & C Detection Kits Market Size, by Product, 2017-2032 (USD Million)
TABLE 319. South Korea Hepatitis B & C Detection Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 320. South Korea Hepatitis B & C Detection Kits Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 321. South Korea Hepatitis B & C Detection Kits Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 322. South Korea Hepatitis B & C Detection Kits Market Size, by Rapid Diagnostic, 2017-2032 (USD Million)
TABLE 323. South Korea Hepatitis B & C Detection Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 324. South Korea Hepatitis B & C Detection Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. South Korea Hepatitis B & C Detection Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Global Hepatitis B & C Detection Kits Market Share, by Key Player, 2025
TABLE 327. Global Hepatitis B & C Detection Kits Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Abcam plc
  • Artron Laboratories Inc.
  • Becton, Dickinson and Company
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • BioMérieux SA
  • Bio‑Rad Laboratories, Inc.
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Fujirebio Holdings, Inc.
  • Genrui Biotech Inc.
  • Hologic, Inc.
  • Immuno Diagnostics (Pvt) Ltd.
  • Immunostics, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • QuidelOrtho Corporation
  • Roche Diagnostics International AG
  • SD Biosensor, Inc.
  • Sekisui Diagnostics LLC
  • Shenzhen Mindray Bio‑Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Snibe Co., Ltd.
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Hepatitis C Virus Saliva Detection Kit Market - Global Forecast 2026-2032 - Product Image

Hepatitis C Virus Saliva Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Viral Hepatitis Test Kit Market - Global Forecast 2026-2032 - Product Image

Viral Hepatitis Test Kit Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Hepatitis Testing - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Hepatitis Testing - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Hepatitis E Virus Rapid Test Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Hepatitis E Virus Rapid Test Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Hepatitis C Virus (HCV) Viral Load Testing Global Market Report 2026 - Product Image

Hepatitis C Virus (HCV) Viral Load Testing Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.